<DOC>
	<DOCNO>NCT01731899</DOCNO>
	<brief_summary>Depression unrefreshed sleep frequent patient fibromyalgia . Agomelatine new antidepressant sleep-promoting property . The objective study include assessment agomelatine therapy patient depression fibromyalgia severity depressive symptomatology sleep quality .</brief_summary>
	<brief_title>Agomelatine Depressed Patients With Fibromyalgia</brief_title>
	<detailed_description>One frequent comorbidities fibromyalgia major depression . Agomelatine new antidepressant whose mechanims action include agonism melatonin receptores 5-HT2C blocking property , addition antidepressant efficacy , show sleep-improving property . As unrefreshed sleep common symptom fibromyalgia hypothetized agomelatine treatment patient concomitant depression fibromyalgia could improve depressive symtomatology sleep quality . Thus , objective present study follow : - ass effectiveness tolerability agomelatine severity depressive symptomatology patient fibromyalgia concomitatnt depresssion - evaluate effect agomelatine treatment sleep quality patient</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Fibromyalgia</mesh_term>
	<mesh_term>Myofascial Pain Syndromes</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>S 20098</mesh_term>
	<criteria>adult patient diagnose fibromyalgia accord American College Rheumatology criterion diagnose major depression accord DSMIV criterion BDIII score equal high tahn 20 psychiastric concomitant illness pregnancy lactation patient previously treat agomelatine little effect</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>major depression</keyword>
	<keyword>fibromyalgia</keyword>
	<keyword>agomelatine</keyword>
	<keyword>Becks ' Depression Inventory ( BDI )</keyword>
	<keyword>Pittsburgh 's Sleep Quality Index ( PSQI )</keyword>
</DOC>